New pill aims to give psoriasis patients their life back

NCT ID NCT05701995

Completed Symptom relief Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the drug deucravacitinib can improve quality of life for adults with moderate-to-severe plaque psoriasis. 180 participants received either the drug or a placebo. The main goal was to see if more people on the drug reported no or minimal impact of their skin condition on daily life after 16 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Show contact details

Locations

Local Institution - 0001

Rochester, New York, 14623, United States
Local Institution - 0002

Waterford, Michigan, 48328, United States
Local Institution - 0003

Baton Rouge, Louisiana, 70809, United States
Local Institution - 0004

Bakersfield, California, 93309, United States
Local Institution - 0005

Bexley, Ohio, 43209, United States
Local Institution - 0006

Phoenix, Arizona, 85006, United States
Local Institution - 0007

Rolling Meadows, Illinois, 60008, United States
Local Institution - 0008

South Jordan, Utah, 84095, United States
Local Institution - 0009

Sacramento, California, 95815, United States
Local Institution - 0010

Auburn Hills, Michigan, 48326, United States
Local Institution - 0012

Mayfield Heights, Ohio, 44124, United States
Local Institution - 0013

New York, New York, 10128, United States
Local Institution - 0014

Spokane, Washington, 99202, United States
Local Institution - 0015

North Little Rock, Arkansas, 72117, United States
Local Institution - 0016

Coral Gables, Florida, 33134, United States
Local Institution - 0017

Las Vegas, Nevada, 89148, United States
Local Institution - 0018

Rockville, Maryland, 20850, United States
Local Institution - 0019

Charleston, South Carolina, 29407, United States
Local Institution - 0020

Snellville, Georgia, 30078, United States
Local Institution - 0021

Bellevue, Washington, 98004, United States
Local Institution - 0022

San Diego, California, 92103, United States
Local Institution - 0024

Washington D.C., District of Columbia, 20016, United States
Local Institution - 0025

Skokie, Illinois, 60077, United States
Local Institution - 0027

Brandon, Florida, 33511, United States
Local Institution - 0028

Frisco, Texas, 75034, United States
Local Institution - 0029

Cypress, Texas, 77433, United States
Local Institution - 0030

Centennial, Colorado, 80111, United States
Local Institution - 0031

Mill Creek, Washington, 98012, United States
Local Institution - 0032

New York, New York, 10011, United States
Local Institution - 0033

Springville, Utah, 84663, United States
Local Institution - 0034

Scottsdale, Arizona, 85260, United States
Local Institution - 0035

Reno, Nevada, 89509, United States
Local Institution - 0036

Springfield, Illinois, 62703, United States
Local Institution - 0037

Atlanta, Georgia, 30331, United States
Local Institution - 0038

Carolina, 00985, Puerto Rico
Local Institution - 0039

San Juan, 00917, Puerto Rico
Local Institution - 0040

Caguas, 00727, Puerto Rico
Riverchase Dermatology

Pembroke Pines, Florida, 33028, United States